Building a Longevity Protocol

A longevity protocol differs from a targeted healing or performance protocol in that it is designed for indefinite use at low, sustainable doses. The foundation is the Trilogy for Life: BPC-157 (anti-inflammatory, gut healing), MOTS-c (metabolic optimizer, exercise mimetic), and Methylene Blue (mitochondrial support, ATP production). These three compounds address all three root causes and can be taken daily as the baseline layer of a longevity stack.

On top of the Trilogy foundation, longevity-specific interventions are layered in cycles. Epitalon cycles (10mg/day for 10-20 days) every 4-6 months for telomere maintenance. NAD+ precursors (NMN 500-1000mg daily) continuously for cellular energy support. GH secretagogues (Ipamorelin + CJC-1295) for maintaining youthful GH pulsatility and all the downstream benefits of growth hormone. Optional quarterly senolytic interventions (FOXO4-DRI or fisetin) for senescent cell clearance. Each layer targets a specific hallmark of aging.

Monitoring a longevity protocol requires more sophisticated biomarkers than a standard protocol. Beyond the basics (CBC, CMP, insulin, inflammatory markers), longevity-focused panels include DNA methylation age testing (GrimAge or DunedinPACE), telomere length measurement, advanced lipid panels (sdLDL, Lp(a), OxLDL), oxidative stress markers (8-OHdG, F2-isoprostanes), and mitochondrial function tests (organic acids panel). Testing frequency depends on the intervention: baseline before starting, 6 months in, then annually. The objective is to demonstrate measurable biological age reduction through multiple independent biomarkers, not just subjective improvement.